Patent · US Active

Insulin formulations

US9481721B2 · kind B2 · utility

10Cited by
33References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 5, 2013
Grant dateNov 1, 2016
Priority date
Expiry dateApr 5, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P3/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A stable pharmaceutical formulation containing an insulin derivative can conveniently be prepared by adding glycerol, phenol, m-cresol and zinc ions to it.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.